| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.097 | 0.003 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.005 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.005 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.099 | 0.005 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |